PANACEABIO.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India...

Stats
本日の出来高	64 506.00
平均出来高	182 133
時価総額	8.39B
EPS	INR0 ( 2024-04-29 )
Last Dividend	INR0.750 ( 2011-09-19 )
Next Dividend	INR0 ( N/A )
P/E	-68.53
ATR14	INR0.205 (0.15%)

ボリューム相関

長: -0.13 (neutral)

短: -0.95 (very strong negative)

Signal:(26.724) Possible Trading Opportunity Present (swing)

Panacea Biotec Limited 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Panacea Biotec Limited 相関 - 通貨/商品

-0.49
( neutral )

-0.72
( moderate negative )

0.00
( neutral )

-0.72
( moderate negative )

0.66
( moderate )

-0.54
( weak negative )

Panacea Biotec Limited 財務諸表

Annual	2022
収益:	INR4.60B
総利益:	INR2.07B (45.07 %)
EPS:	INR-5.51

FY	2022
収益:	INR4.60B
総利益:	INR2.07B (45.07 %)
EPS:	INR-5.51

FY	2022
収益:	INR6.59B
総利益:	INR3.59B (54.49 %)
EPS:	INR175.98

FY	2021
収益:	INR6.18B
総利益:	INR3.89B (63.00 %)
EPS:	INR-24.11

Financial Reports:

No articles found.

Panacea Biotec Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Panacea Biotec Limited Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 1.043 - No dividend growth expected in the near future

Information

First Dividend	INR1.000	2002-08-13
Last Dividend	INR0.750	2011-09-19
Next Dividend	INR0	N/A
Payout Date	2011-10-10
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	INR8.50	--
Avg. Dividend % Per Year	0.00%	--
Score	0.73	--
Div. Sustainability Score	0
Div.Growth Potential Score	1.043
Div. Directional Score	0.471	--

Next Divdend (Est)
(2024-05-17)

INR0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

0.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2002	INR0	0.00%
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
REDINGTON.NS	Dividend Knight	2023-07-06	Annually	18	3.28%
KPITTECH.NS	Dividend Knight	2023-08-14	Annually	6	0.47%
FACT.NS	Dividend Junior	2023-09-22	Insufficient data to determine frequency	2	0.09%
AMRUTANJAN.NS	Dividend Knight	2023-09-14	Semi-Annually	15	0.38%
TASTYBITE.NS	Dividend Junior	2023-07-14	Annually	8	0.01%
NH.NS	Dividend Junior	2023-07-06	Sporadic	6	0.14%
IMPAL.NS	Dividend Junior	2023-07-20	Annually	19	1.79%
CHEVIOT.NS	Dividend Junior	2023-08-03	Annually	3	1.62%
SALASAR.NS	Dividend Junior	2023-09-15	Annually	8	1.41%
LUPIN.NS	Dividend Junior	2023-07-14	Annually	23	0.37%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0222	1.500	-0.445	-0.667	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.0145	1.500	-1.273	-1.909	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	2.63	1.000	-0.137	-0.137	[3 - 30]
operatingCashFlowPerShareTTM	12.22	2.00	5.93	10.00	[0 - 30]
freeCashFlowPerShareTTM	12.22	2.00	3.89	7.78	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.484	1.000	5.27	5.27	[0.2 - 0.8]
operatingProfitMarginTTM	-0.107	1.000	-4.14	-4.14	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.101

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-68.74	1.000	-7.04	0	[1 - 100]
returnOnEquityTTM	-0.0145	2.50	-0.818	-1.909	[0.1 - 1.5]
freeCashFlowPerShareTTM	12.22	2.00	5.93	7.78	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	12.22	2.00	5.93	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.459	1.500	-6.40	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.136	1.000	9.11	0	[0.1 - 0.5]
Total Score				1.043

Panacea Biotec Limited

Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care; and vaccines for anthrax, dengue, Japanese encephalitis, and others. It also exports its products to over 30 countries worldwide, including the United States, Germany, the Russian Federation, Sri Lanka, the Philippines, etc. The company has a collaboration agreement with the Russian Direct Investment Fund for producing Covid-19 vaccine Sputnik-V; and the Coalition for Epidemic Preparedness Innovations and Translational Health Science and Technology Institute to develop vaccine candidates that could protect against SARS-Cov-2 variants and other Beta coronaviruses. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.